NBC Securities’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$692K Sell
6,269
-4,145
-40% -$400K 0.05% 414
2026
Q2
$815K Sell
10,414
-866
-8% -$59K 0.06% 359
2026
Q1
$729K Hold
11,280
– – 0.05% 363
2025
Q4
$759K Sell
11,280
-364
-3% -$24.5K 0.06% 347
2025
Q3
$854K Buy
11,644
+17
+0.1% +$1.13K 0.07% 324
2025
Q2
$604K Sell
11,627
-776
-6% -$44.2K 0.05% 418
2025
Q1
$791K Buy
12,403
+12,401
+620,050% +$720K 0.07% 301
2024
Q4
$120 Sell
2
-2,301
-100% -$118K 0.01% 890
2024
Q3
$131K Sell
2,303
-821
-26% -$47.1K 0.01% 911
2024
Q2
$163K Buy
3,124
+1,902
+156% +$83.4K 0.01% 816
2024
Q1
$49K Hold
1,222
– – ﹤0.01% 1140
2023
Q4
$45K Sell
1,222
-156
-11% -$5.88K ﹤0.01% 1156
2023
Q3
$52K Buy
+1,378
New +$56.4K 0.01% 1120

Other funds holding HALO

NBC Securities's HALO Position: Q3 2026 in Review

NBC Securities reduced its Halozyme (HALO) stake by 40% in Q3 2026, selling an estimated $400K and leaving 6,269 shares worth $692K. The position accounts for 0.05% of the portfolio, ranked #414.

NBC Securities first reported a position in HALO in Q3 2023 and has held it in 13 quarters since. The position peaked at $854K in Q3 2025. 218 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • NBC Securities held 6,269 shares of Halozyme worth $692K as of Q3 2026.
  • NBC Securities sold 4,145 Halozyme shares in Q3 2026, an estimated $400K.
  • Halozyme made up 0.05% of NBC Securities's portfolio in Q3 2026, its #414 holding.
  • NBC Securities first reported a position in Halozyme in Q3 2023 and has held it in 13 quarters since.
  • NBC Securities's Halozyme position peaked at $854K in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.